ID

27317

Beschreibung

Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00437359

Link

https://clinicaltrials.gov/show/NCT00437359

Stichworte

  1. 08.11.17 08.11.17 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

8. November 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Neoplasms NCT00437359

Eligibility Breast Neoplasms NCT00437359

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
written consent obtained for study participation.
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
breast cancer diagnosed histologically with a breast removed or preserved.
Beschreibung

Breast Carcinoma | Mastectomy | Breast Preserved

Datentyp

boolean

Alias
UMLS CUI [1]
C0678222
UMLS CUI [2]
C0024881
UMLS CUI [3,1]
C0006141
UMLS CUI [3,2]
C0033085
positive er or pr testing by immunohistochemistry (ihc), enzyme immunoassay (eia) and who meet the criteria of each institution.
Beschreibung

Estrogen receptor positive Immunohistochemistry | Progesterone receptor positive Immunohistochemistry | Estrogen receptor positive Enzyme Immunoassay | Progesterone receptor positive Enzyme Immunoassay

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0279754
UMLS CUI [1,2]
C0021044
UMLS CUI [2,1]
C0279759
UMLS CUI [2,2]
C0021044
UMLS CUI [3,1]
C0279754
UMLS CUI [3,2]
C0086231
UMLS CUI [4,1]
C0279759
UMLS CUI [4,2]
C0086231
her2 evaluation.
Beschreibung

HER2/Neu Status Evaluation

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1512413
UMLS CUI [1,2]
C1261322
patient status (ps): 0 or 1.
Beschreibung

Performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1518965
fully functional heart, liver, kidneys, and bone marrow.
Beschreibung

Cardiac function | Liver function | Renal function | Bone Marrow function

Datentyp

boolean

Alias
UMLS CUI [1]
C0232164
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
UMLS CUI [4,1]
C0005953
UMLS CUI [4,2]
C0031843
more than one year since last menstruation or tested postmenopausal from estradiol (e2) and follicle-stimulating hormone (fsh) levels based on evaluation standard of each institution.
Beschreibung

Postmenopausal state Estradiol measurement | Postmenopausal state Follicle stimulating hormone measurement

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0232970
UMLS CUI [1,2]
C0337434
UMLS CUI [2,1]
C0232970
UMLS CUI [2,2]
C0202022
expected to live for at least three months (or longer) after study commencement.
Beschreibung

Life Expectancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or breast feeding.
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
bilateral or inflammatory breast cancer.
Beschreibung

Bilateral breast cancer | Inflammatory Breast Carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C0281267
UMLS CUI [2]
C0278601
multiple cancers.
Beschreibung

Multiple malignancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0346429
life-threatening metastases.
Beschreibung

Neoplasm Metastasis Life Threatening

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C2826244
history of serious hypersensitivity.
Beschreibung

Hypersensitivity Serious

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0205404
judged ineligible for the study by the study doctor.
Beschreibung

Ineligibility Clinical Trial

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1512714
UMLS CUI [1,2]
C0008976

Ähnliche Modelle

Eligibility Breast Neoplasms NCT00437359

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
written consent obtained for study participation.
boolean
C0021430 (UMLS CUI [1])
Breast Carcinoma | Mastectomy | Breast Preserved
Item
breast cancer diagnosed histologically with a breast removed or preserved.
boolean
C0678222 (UMLS CUI [1])
C0024881 (UMLS CUI [2])
C0006141 (UMLS CUI [3,1])
C0033085 (UMLS CUI [3,2])
Estrogen receptor positive Immunohistochemistry | Progesterone receptor positive Immunohistochemistry | Estrogen receptor positive Enzyme Immunoassay | Progesterone receptor positive Enzyme Immunoassay
Item
positive er or pr testing by immunohistochemistry (ihc), enzyme immunoassay (eia) and who meet the criteria of each institution.
boolean
C0279754 (UMLS CUI [1,1])
C0021044 (UMLS CUI [1,2])
C0279759 (UMLS CUI [2,1])
C0021044 (UMLS CUI [2,2])
C0279754 (UMLS CUI [3,1])
C0086231 (UMLS CUI [3,2])
C0279759 (UMLS CUI [4,1])
C0086231 (UMLS CUI [4,2])
HER2/Neu Status Evaluation
Item
her2 evaluation.
boolean
C1512413 (UMLS CUI [1,1])
C1261322 (UMLS CUI [1,2])
Performance status
Item
patient status (ps): 0 or 1.
boolean
C1518965 (UMLS CUI [1])
Cardiac function | Liver function | Renal function | Bone Marrow function
Item
fully functional heart, liver, kidneys, and bone marrow.
boolean
C0232164 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0005953 (UMLS CUI [4,1])
C0031843 (UMLS CUI [4,2])
Postmenopausal state Estradiol measurement | Postmenopausal state Follicle stimulating hormone measurement
Item
more than one year since last menstruation or tested postmenopausal from estradiol (e2) and follicle-stimulating hormone (fsh) levels based on evaluation standard of each institution.
boolean
C0232970 (UMLS CUI [1,1])
C0337434 (UMLS CUI [1,2])
C0232970 (UMLS CUI [2,1])
C0202022 (UMLS CUI [2,2])
Life Expectancy
Item
expected to live for at least three months (or longer) after study commencement.
boolean
C0023671 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
pregnant or breast feeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Bilateral breast cancer | Inflammatory Breast Carcinoma
Item
bilateral or inflammatory breast cancer.
boolean
C0281267 (UMLS CUI [1])
C0278601 (UMLS CUI [2])
Multiple malignancy
Item
multiple cancers.
boolean
C0346429 (UMLS CUI [1])
Neoplasm Metastasis Life Threatening
Item
life-threatening metastases.
boolean
C0027627 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
Hypersensitivity Serious
Item
history of serious hypersensitivity.
boolean
C0020517 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Ineligibility Clinical Trial
Item
judged ineligible for the study by the study doctor.
boolean
C1512714 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video